 |
|
Treatment of Extracutaneous Sporotrichosis
James D. Parker, MD;
George A. Sarosi, MD;
Fred E. Tosh, MD, MPH
Arch Intern Med. 1970;125(5):858-863.
Abstract
Six of 9 patients with extracutaneous sporotrichosis in the present series, and, to our knowledge, 15 patients previously reported in the literature were treated with amphotericin B. Of 21 patients treated with the drug, five of the seven with pulmonary disease alone and eight of the 14 with disseminated extrapulmonary disease responded well to amphotericin B alone or in combination with other therapy. Eleven of the 21 patients were given iodides alone or together with hydroxystilbamidine isethionate or griseofulvin. All responded poorly to these drugs or relapsed. These data suggest that amphotericin B is more effective than iodides in the treatment of extracutaneous sporotrichosis. However, a prospective study comparing amphotericin B with iodide therapy is needed to determine if the apparent superiority of amphotericin B is real.
Author Affiliations
Kansas City, Kan
From the Ecological Investigations Program, National Communicable Disease Center, Health Services and Mental Health Administration, Public Health Service, Kansas City, Kan.
Footnotes
Received for publication Sept 24, 1969; accepted Nov 12.
Reprint requests to 2002 W 39th St, Kansas City, Kan 66103 (Dr. Tosh).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Spontaneous Remission of Extensive Pulmonary Sporotrichosis
PUERINGER et al.
ANN INTERN MED 1986;104:366-367.
ABSTRACT
Ketoconazole in Systemic Mycoses
HOEPRICH
ANN INTERN MED 1983;98:105-105.
ABSTRACT
Disseminated Cutaneous Sporotrichosis: Three Illustrative Cases
Smith et al.
Arch Dermatol 1981;117:143-144.
ABSTRACT
|
